Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CRSP - Crispr beats in Q4 as Casgevy approval boosts topline

CRSP - Crispr beats in Q4 as Casgevy approval boosts topline

February, 21 2024 08:48 AM CRISPR Therapeutics AG

2024-02-21 08:48:22 ET

More on CRISPR Therapeutics

Crispr Therapeutics: Investors Bet Against Casgevy Uptake
Biotech And Pharma Diversification Pays Off
Vertex And Crispr: Second Casgevy Approval Pushes Revenue Potential Into Multi-Billion Dollar Range
Is Crispr Therapeutics’ high short interest justifiable?
Crispr, Intellia, and Recursion gain as Ark ETFs boost stakes

For further details see:

Crispr beats in Q4 as Casgevy approval boosts topline

Stock Information

Company Name:	CRISPR Therapeutics AG
Stock Symbol:	CRSP
Market:	NASDAQ
Website:	crisprtx.com

CRSP CRSP Quote CRSP Short CRSP News CRSP Articles CRSP Message Board

Get CRSP Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.